Report - Η ΝΕΑ ΕΠΑΝΑΣΤΑΣΗ ΣΤΗΝ ...€¦ · OSLER: Safety and Tolerability 27 Adverse events, % SOC N = 368 Evolocumab + SOC N = 736 Any adverse event 73.1 81.4 Serious 6.3

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form